According to research report the global Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2027, The global interventional cardiology devices market size is projected to reach USD 25.5 billion by 2027 from USD 17.5 billion in 2022, at a CAGR of 7.7%. Market is driven by factors such as growing prevalence of coronary artery disease and increasing consumption of tobacco. Emerging economies growth potential is anticipated to propel market growth opportunities. However, low affordability and inaccessibility of cardiac surgeries in developing countries is anticipated to hinder market development.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548Browse 179 market data Tables and 38 Figures spread through 196 Pages and in-depth TOC on "Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2027"View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.htmlThe old/normal balloons segment accounted for the largest share of the angioplasty balloons market in 2019.Based on type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. In 2019, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market. The large share of this segment can be attributed to a increasing its use in impating the stents and structural heart devices; and increasing prevalence of vaulvuloplasty.Thrombectomy devices segment accounted for the largest share of the plaque modification devices market in 2019.Based on type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices. In 2019, the thrombectomy devices segment accounted for the largest share of the plaque modification devices market. Growth in this market segment can largely be attributed to the increasing incidence of blood clots and atrial embolisms across the globe.Angioplasty stents in product segment to witness the highest growth rate during the forecast period.Based on the Product, the interventional cardiology devices is classified into angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, and other interventional cardiology devices. The angioplasty stents segment is expected to dominate because of technological advancements and companies developing innovative drug-eluting stents to enhance the strength and flexibility of these devices.US dominates the North American Interventional cardiology devices Market.Based on the North America region, the Interventional cardiology devices Market is divided into US and Canada. US is expected to dominate the Interventional cardiology devices Market. The availability of reimbursements for interventional cardiology surgeries and the large base of major device manufacturers in the country are the key factor driving market growth in the US.
Request Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=548Some of the major players in the interventional cardiology devices market include Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Edward Lifescinces Corporation (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA : [email protected]